Assignment of Assignor's Interest

Recorded: 2025-01-14 Pages: 3

Assignor

REGEN BIOPHARMA, INC.

Executed: 2018-12-14

Assignee

KCL THERAPEUTICS, INC.

4700 SPRING ST, SUITE 304, LA MESA, CALIFORNIA, 91942

Covered Property (1)

Small Molecule Agonists and Antagonists of NR2F6 Activity in Humans

Application: 17/698,924 →

Publication: US 2022/0249436

Related Assignments (1)

Other recorded transfers of the patent in this record — the chain of ownership.